Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Analysis (1)
- CGMP (1)
- Case Study (1)
- Consulting (1)
- Data analytics (1)
-
- Egypt (1)
- Healthcare (1)
- Healthcare industry (1)
- Johnson & Johnson (1)
- Optum (1)
- PBMs (1)
- Pediatric oncology (1)
- Performance management system (1)
- Pharmaceutical Industry (1)
- Pharmaceutical manufacturing (1)
- Quality by design (1)
- Strategic Audit (1)
- Strategic Management (1)
- Strategy (1)
- UnitedHealth (1)
Articles 1 - 5 of 5
Full-Text Articles in Medicine and Health Sciences
Johnson & Johnson Strategic Audit, Hannah Headley, Lucy Peterkin, Ryan Nyffeler, Joshua Wiemers, Bailey Birkholtz
Johnson & Johnson Strategic Audit, Hannah Headley, Lucy Peterkin, Ryan Nyffeler, Joshua Wiemers, Bailey Birkholtz
Honors Theses
Johnson & Johnson (J&J) is a healthcare company that generates economic value from its three core business segments: Consumer Health, Pharmaceuticals, and Medical Devices. Recent innovations include new pharmaceutical products, remote clinical trials, automated patient recruitment, improved scientific and digital literacy amongst employees, and innovative digitized models for supply chain planning. J&J has a competitive edge in R&D efficiency, with a 4.35 return on research capital ratio. Sociocultural, technological, and economic factors will play a large role in changing the pharmaceutical industry environment, and J&J is well positioned to benefit from sources of growth such as the increase in aging …
Takeda Pharmaceutical Rare Hematology Strategic Audit, Brian Duval
Takeda Pharmaceutical Rare Hematology Strategic Audit, Brian Duval
Honors Theses
Takeda Pharmaceutical Company is a large Japanese-based multinational pharmaceutical company that manufactures treatments for many different diseases. It is the largest pharmaceutical company in Asia and has a significant share in markets across the world. This report focuses specifically on Takeda’s treatments for rare bleeding disorders under its Rare Diseases & Hematology division. Using internal and external analysis tools, this report seeks to understand how Takeda has created and sustained competitive advantages in the complex environment of the pharmaceutical industry. Specific tools used to highlight this include Porter’s Five Forces and PESTEL analyses. This report also examines the environment surrounding …
Egypt’S Pediatric Oncology Hospital 57357: A Case Study Analysis, Ashley A. Clegg
Egypt’S Pediatric Oncology Hospital 57357: A Case Study Analysis, Ashley A. Clegg
Honors Theses
Hospital 57357 is the foremost pediatric oncology hospital in Egypt and provides treatment free of charge to children with cancer. Since its establishment in 2007, the hospital has grown to a capacity of 380 patient beds across three locations. Its quest for continuous improvement led to the development of a new performance management system emphasizing the tracking and measurement of a multitude of Key Performance Indicators across all departments. While this new system enables objective and perpetual monitoring of key patient care metrics, its integration into the existing structure introduces challenges that must be addressed. To analyze the external environment …
Strategic Audit Of Optum, Connor Crow
Strategic Audit Of Optum, Connor Crow
Honors Theses
Optum is a large American-based pharmacy benefit manager, healthcare consultant, healthcare delivery service, and business analytics corporation that has dominated the industry with sister-company UnitedHealthcare underneath the umbrella UnitedHealthGroup. This report seeks to understand through internal and external analyses how Optum’s business model and strategies have allowed them to gain and sustain competitive advantages in the everchanging, volatile environment of healthcare. Specific tools used to highlight this include Porter’s Five Forces, PESTEL, and SWOT analyses. Additionally, strategic recommendations are given for Optum’s next steps.
Pharmaceutical Manufacturing In The 21st Century: Identification And Analysis Of Key Elements, Robert N. Mills
Pharmaceutical Manufacturing In The 21st Century: Identification And Analysis Of Key Elements, Robert N. Mills
Honors Theses
The availability of quality pharmaceutical products impacts the lives of the global population on a daily basis. The importance of product availability and quality within pharmaceutical manufacturing requires that quality systems put into place are capable of accurately and robustly capturing the quality compliance, or lack thereof, of the various stages of production. This review intends to analyze current expert-recommended best practices within key elements of a pharmaceutical manufacturing quality control system and provide recommendations throughout. The quality elements discussed include Quality by Design method validation, necessary equipment determination, and equipment qualification, followed by documentation control and data flow.